A detailed history of Gabelli Funds LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Gabelli Funds LLC holds 13,722 shares of HAE stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,722
Previous 10,682 28.46%
Holding current value
$1.01 Million
Previous $796,000 16.08%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$47.67 - $78.17 $144,916 - $237,636
3,040 Added 28.46%
13,722 $668,000
Q2 2025

Aug 13, 2025

BUY
$56.04 - $74.77 $598,619 - $798,693
10,682 New
10,682 $796,000
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $336,765 - $770,640
6,500 New
6,500 $433,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.